65 results
8-K
EX-10.1
42nek0l3ch7nkx
6 May 24
Entry into a Material Definitive Agreement
4:11pm
8-K
EX-4.2
pfq iskznd8yym3wro2
6 May 24
Entry into a Material Definitive Agreement
4:11pm
8-K
EX-4.1
cygnul86c
6 May 24
Entry into a Material Definitive Agreement
4:11pm
424B5
8b98 r2s3
3 May 24
Prospectus supplement for primary offering
4:05pm
8-K
EX-99.1
ock2jhe
7 Nov 23
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results
4:03pm